Intrinsiqq
Cybin Inc. logo

Cybin Inc. Insider Trading

HELP

Compare
Cluster buy

4 insiders bought $9.67M of their own stock in 30 days.

Open-market purchases by executives and directors between Aug 31 and Sep 29. Buying is rarer than selling and says more, but it is one input, not a verdict.

Net open-market
+$9.67M
9 buys · 0 sales
Under a 10b5-1 plan
—
no sales
Insiders who bought / sold
4 / 0
executives and directors
Last open-market buy
Sep 2026
Sep 29, 2026

Get an email when HELP's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Sep 29
    Greg Cavers
    Chief Financial Officer · bought 3,000 at $12.91
    39K
    2.4% of stake
  • Sep 21
    Michael Halstead
    Chief Executive Officer · bought 100,000 at $13.47
    $1.35M
    146% of stake
  • Sep 8
    Paul Glavine
    Chief Growth Officer · bought 100,000 at $12.47
    $1.25M
    2.3% of stake
  • Sep 8
    Paul Glavine
    Chief Growth Officer · bought 100,000 at $12.47
    $1.25M
    2.3% of stake
  • Sep 8
    Eric H. L. So
    Executive Chair · bought 100,000 at $12.39
    $1.24M
    2.3% of stake
  • Sep 4
    Eric H. L. So
    Executive Chair · bought 100,000 at $12.09
    $1.21M
    2.3% of stake
  • Sep 3
    Paul Glavine
    Chief Growth Officer · bought 100,000 at $11.78
    $1.18M
    2.3% of stake
  • Sep 1
    Eric H. L. So
    Executive Chair · bought 95,000 at $11.81
    $1.12M
    2.2% of stake
  • Aug 31
    Paul Glavine
    Chief Growth Officer · bought 90,000 at $11.59
    $1.04M
    2.1% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch HELP, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Biotechnology · Pick stocks to compare with HELP

CompareIntrinsic value
NEWBRY.XSTONewbury Pharmaceuticals AB
€0.11+0.91%40
HPHA.XETRHeidelberg Pharma AG
€2.01-2.90%10
MEDCL.XPARMedincell SA
€26.70-2.05%40
ZTEKZentek Ltd.
€0.33-0.60%40
XTXXFAdastra Holdings Ltd.
€0.08+0.00%40
XRTXXORTX Therapeutics Inc.
$0.84-5.73%10
VALNValneva SE Sponsored ADR
$5.16-3.82%0
TRIBTrinity Biotech plc Sponsored ADR
$6.24+13.66%10

Spot a number that looks wrong?

Download this analysis as a PDF (Pro)

Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing HELP

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.